A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2439440
The present invention relates to the use of PDGF receptor tyrosine kinase or bcr-abl tyrosine kinase inhibitors, especially of N-phenyl-2-pyrimidine-amine derivatives of formula I, Image in which the symbols and substituents have the meaning as defined herein in free form or in pharmaceutically acceptable salt form, in the manufacture of a pharmaceutical composition for the treatment of tuberous sclerosis associated neoplasms; to a method of treatment of warm- blooded animals, including humans, suffering from a tuberous sclerosis associated neoplasms.
Emory University
Fetherstonhaugh & Co.
LandOfFree
Treatment of tuberous sclerosis associated neoplasms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of tuberous sclerosis associated neoplasms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tuberous sclerosis associated neoplasms will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936275